Menu
Back to Journals » Biologics: Targets and Therapy » Volume 12
Review
Two decades with omalizumab: what we still have to learn
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,059 | Dovepress* | 14,681+ | 1,531 | 16,212 | |
| PubMed Central* | 4,378 | 876 | 5,254 | ||
| Totals | 19,059 | 2,407 | 21,466 | ||
| *Since 26 October 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar